This company has been marked as potentially delisted and may not be actively trading.

Day One Biopharmaceuticals (DAWN) Institutional Ownership

Current Institutional Ownership Percentage: 87.95%
Number of Institutional Buyers (last 12 months): 127
Total Institutional Inflows (last 12 months): $426.16M

Number of Institutional Sellers (last 12 months): 59
Total Institutional Outflows (last 12 months): $155.70M

Get DAWN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Day One Biopharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DAWN Institutional Buying and Selling by Quarter

Day One Biopharmaceuticals Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/21/2026	Groupe la Francaise	179,495	$3.85M	0.1%	N/A	0.174%
5/19/2026	Western Wealth Management LLC	8,005	$172K	0.0%	N/A	0.008%
5/19/2026	Bank of America Corp DE	1,902,868	$40.80M	0.0%	+75.6%	1.842%
5/19/2026	Janus Henderson Group PLC	546,428	$11.71M	0.0%	+2,465.4%	0.529%
5/19/2026	Oddo BHF Asset Management Sas	1,550,000	$33.23M	1.3%	N/A	1.500%
5/18/2026	ADAR1 Capital Management LLC	49,923	$1.07M	0.1%	N/A	0.048%
5/18/2026	California State Teachers Retirement System	67,463	$1.45M	0.0%	-6.6%	0.065%
5/18/2026	Royal Bank of Canada	1,911	$41K	0.0%	-53.5%	0.002%
5/18/2026	Eversept Partners LP	183,902	$3.94M	0.2%	N/A	0.178%
5/16/2026	The Manufacturers Life Insurance Company	36,186	$776K	0.0%	+49.3%	0.035%
Get the Latest News and Ratings for DAWN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Day One Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
5/16/2026	Quantinno Capital Management LP	17,556	$376K	0.0%	+9.8%	0.017%
5/16/2026	Polar Asset Management Partners Inc.	630,410	$13.52M	0.3%	N/A	0.610%
5/16/2026	Lazard Asset Management LLC	9,364	$201K	0.0%	-59.4%	0.009%
5/15/2026	Kryger Capital LLC	3,896,485	$83.54M	5.9%	N/A	3.771%
5/15/2026	Entropy Technologies LP	17,040	$365K	0.0%	-42.0%	0.016%
5/14/2026	Healthcare of Ontario Pension Plan Trust Fund	643,738	$13.80M	0.0%	N/A	0.623%
5/14/2026	Renaissance Technologies LLC	1,296,984	$27.81M	0.0%	-0.6%	1.255%
5/14/2026	Gabelli Funds LLC	464,097	$9.95M	0.1%	N/A	0.449%
5/14/2026	GABELLI & Co INVESTMENT ADVISERS INC.	325,350	$6.98M	1.0%	N/A	0.315%
5/14/2026	Arrowstreet Capital Limited Partnership	15,294	$328K	0.0%	-94.0%	0.015%
5/14/2026	Sei Investments Co.	104,598	$2.24M	0.0%	+178.8%	0.101%
5/7/2026	Dimensional Fund Advisors LP	819,371	$17.57M	0.0%	-21.0%	0.793%
5/5/2026	Bank of New York Mellon Corp	231,043	$4.95M	0.0%	+9.2%	0.224%
5/4/2026	ABC Arbitrage SA	228,817	$4.91M	0.7%	N/A	0.221%
5/1/2026	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	26,500	$568K	0.0%	N/A	0.026%
4/29/2026	Credit Industriel ET Commercial	135,420	$2.90M	0.2%	N/A	0.131%
4/27/2026	Chicago Capital Management LLC	10,000	$214K	0.0%	N/A	0.010%
4/25/2026	Strs Ohio	37,900	$813K	0.0%	+34.9%	0.037%
4/23/2026	Inspire Investing LLC	18,911	$405K	0.0%	N/A	0.018%
4/22/2026	Pictet Asset Management Holding SA	13,034	$279K	0.0%	-99.6%	0.013%
4/22/2026	Sterling Capital Management LLC	2,493	$53K	0.0%	-43.9%	0.002%
4/16/2026	SG Americas Securities LLC	122,922	$2.64M	0.0%	-64.9%	0.119%
3/20/2026	Hsbc Holdings PLC	49,333	$455K	0.0%	-55.1%	0.048%
2/19/2026	Invesco Ltd.	123,994	$1.16M	0.0%	+26.5%	0.121%
2/18/2026	Oracle Investment Management Inc.	100,000	$932K	0.6%	N/A	0.097%
2/18/2026	XTX Topco Ltd	128,440	$1.20M	0.0%	+62.9%	0.125%
2/18/2026	VARCOV Co.	28,016	$261K	0.1%	N/A	0.027%
2/18/2026	Vestal Point Capital LP	5,200,000	$48.46M	1.6%	+94.4%	5.064%
2/18/2026	Virtus Investment Advisers LLC	81,747	$762K	0.2%	+23.1%	0.080%
2/18/2026	Susquehanna Portfolio Strategies LLC	57,379	$535K	0.0%	-38.0%	0.056%
Trump's gold order: the announcement they won't put on the front page (Ad) On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free. Request the free guide in 30 seconds and get positioned now
2/18/2026	Sphera Funds Management LTD.	145,371	$1.36M	0.3%	-17.1%	0.142%
2/18/2026	Millennium Management LLC	1,349,919	$12.58M	0.0%	+94.7%	1.315%
2/18/2026	Man Group plc	197,096	$1.84M	0.0%	+114.7%	0.192%
2/18/2026	Balyasny Asset Management L.P.	1,489,924	$13.89M	0.0%	+7.6%	1.451%
2/18/2026	ACT Capital Management LLC	12,900	$120K	0.1%	N/A	0.013%
2/17/2026	Logos Global Management LP	300,000	$2.80M	0.2%	N/A	0.292%
2/17/2026	Schonfeld Strategic Advisors LLC	300,102	$2.80M	0.0%	+1,186.9%	0.292%
2/17/2026	PDT Partners LLC	24,300	$226K	0.0%	N/A	0.024%
2/17/2026	AQR Capital Management LLC	431,758	$4.02M	0.0%	+298.0%	0.420%
2/17/2026	Cetera Investment Advisers	35,000	$326K	0.0%	-11.5%	0.034%
2/17/2026	Lazard Asset Management LLC	23,065	$215K	0.0%	+60.6%	0.022%
2/17/2026	Mak Capital One LLC	826,205	$7.70M	0.8%	-43.0%	0.805%
2/17/2026	Jump Financial LLC	667,120	$6.22M	0.1%	+144.8%	0.650%
2/17/2026	Price T Rowe Associates Inc. MD	102,456	$955K	0.0%	+28.5%	0.100%
2/17/2026	Osaic Holdings Inc.	39,490	$368K	0.0%	+5.9%	0.038%
2/17/2026	Public Employees Retirement System of Ohio	34,267	$319K	0.0%	N/A	0.033%
2/17/2026	Russell Investments Group Ltd.	143,079	$1.33M	0.0%	-4.8%	0.139%
2/17/2026	State of Wisconsin Investment Board	23,426	$218K	0.0%	-13.2%	0.023%
2/17/2026	ExodusPoint Capital Management LP	39,321	$366K	0.0%	-35.5%	0.038%
2/17/2026	Royal Bank of Canada	4,108	$38K	0.0%	-90.7%	0.004%
2/17/2026	Graham Capital Management L.P.	50,355	$469K	0.0%	N/A	0.049%
2/16/2026	Squarepoint Ops LLC	100,612	$938K	0.0%	N/A	0.098%
2/16/2026	Mariner LLC	31,167	$290K	0.0%	N/A	0.030%
2/16/2026	Kennedy Capital Management LLC	542,848	$5.06M	0.1%	+0.5%	0.529%
2/16/2026	Landscape Capital Management L.L.C.	33,898	$316K	0.0%	N/A	0.033%
2/16/2026	Entropy Technologies LP	29,379	$274K	0.0%	N/A	0.029%
2/13/2026	The Manufacturers Life Insurance Company	24,243	$226K	0.0%	-4.8%	0.024%
2/13/2026	Hudson Bay Capital Management LP	1,700,000	$15.84M	0.1%	+28.8%	1.656%
2/13/2026	Virtus Advisers LLC	11,200	$104K	0.0%	N/A	0.011%
2/13/2026	Schroder Investment Management Group	569,624	$5.23M	0.0%	+110.8%	0.555%
2/13/2026	Jacobs Levy Equity Management Inc.	729,281	$6.80M	0.0%	N/A	0.710%
2/13/2026	Rafferty Asset Management LLC	157,010	$1.46M	0.0%	+23.1%	0.153%
2/13/2026	Charles Schwab Investment Management Inc.	633,694	$5.91M	0.0%	+3.9%	0.617%
2/13/2026	State Street Corp	4,289,566	$39.98M	0.0%	+32.4%	4.178%
2/13/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	124,422	$1.16M	0.0%	+7.0%	0.121%
2/13/2026	Wells Fargo & Company MN	114,716	$1.07M	0.0%	+40.8%	0.112%
2/13/2026	Atlas Venture Life Science Advisors LLC	6,412,560	$59.77M	6.9%	-0.3%	6.245%
2/12/2026	HRT Financial LP	450,938	$4.20M	0.0%	+40.3%	0.439%
2/12/2026	DRW Securities LLC	11,635	$108K	0.0%	-65.0%	0.011%
2/12/2026	MetLife Investment Management LLC	43,664	$407K	0.0%	+16.5%	0.043%
2/12/2026	Renaissance Technologies LLC	1,305,084	$12.16M	0.0%	+44.1%	1.271%
2/12/2026	Dimensional Fund Advisors LP	1,037,312	$9.67M	0.0%	-15.2%	1.010%
2/12/2026	Federated Hermes Inc.	2,730	$25K	0.0%	-51.1%	0.003%
2/12/2026	AlphaCentric Advisors LLC	26,812	$250K	0.2%	N/A	0.026%
2/12/2026	Knott David M Jr	25,884	$241K	0.1%	-80.2%	0.025%
2/12/2026	Alps Advisors Inc.	84,304	$786K	0.0%	+71.9%	0.082%
2/12/2026	Swiss National Bank	141,500	$1.32M	0.0%	+12.5%	0.138%
2/12/2026	Nuveen LLC	522,455	$4.87M	0.0%	+247.4%	0.509%
2/11/2026	Deutsche Bank AG	57,010	$531K	0.0%	+37.4%	0.056%
2/11/2026	Fox Run Management L.L.C.	33,639	$314K	0.0%	+29.7%	0.033%
Before you buy SpaceX shares, consider this alternative approach (Ad) SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered. Discover the overlooked SpaceX IPO strategy before the June listing
2/11/2026	Cerity Partners LLC	11,586	$108K	0.0%	N/A	0.011%
2/11/2026	LPL Financial LLC	10,900	$102K	0.0%	N/A	0.011%
2/11/2026	Franklin Resources Inc.	52,726	$491K	0.0%	-98.5%	0.051%
2/11/2026	Los Angeles Capital Management LLC	100,314	$935K	0.0%	+1.4%	0.098%
2/10/2026	Goldman Sachs Group Inc.	1,506,234	$14.04M	0.0%	+9.8%	1.467%
2/10/2026	AXQ Capital LP	32,405	$302K	0.1%	+98.7%	0.032%
2/10/2026	BNP Paribas Financial Markets	453,311	$4.23M	0.0%	+69.0%	0.441%
2/10/2026	Norges Bank	169,000	$1.58M	0.0%	N/A	0.165%
2/10/2026	Intech Investment Management LLC	36,058	$336K	0.0%	+15.3%	0.035%
2/9/2026	Geode Capital Management LLC	1,877,838	$17.51M	0.0%	+6.6%	1.829%

DAWN Institutional Ownership - Frequently Asked Questions

During the previous two years, 213 institutional investors and hedge funds held shares of Day One Biopharmaceuticals. The most heavily invested institutionals were FMR LLC ($163.28M), Kryger Capital LLC ($83.54M), RA Capital Management L.P. ($72.92M), Atlas Venture Life Science Advisors LLC ($59.77M), Vanguard Group Inc. ($58.55M), Vestal Point Capital LP ($48.46M), and Bank of America Corp DE ($40.80M).Learn more on Day One Biopharmaceuticals' institutional investors.

87.95% of Day One Biopharmaceuticals' stock is owned by institutional investors. Learn more on DAWN's institutional investor holdings.

Of the 186 institutional investors that purchased Day One Biopharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($10.23M), Vestal Point Capital LP ($5.34M), Alyeska Investment Group L.P. ($4.06M), Kryger Capital LLC ($3.90M), Rubric Capital Management LP ($3.38M), AIGH Capital Management LLC ($1.99M), and Millennium Management LLC ($1.87M).

Institutional investors have bought a total of 36,571,533 shares in the last 24 months. This purchase volume represents approximately $426.16M in transactions.

Of the 59 institutional investors that sold Day One Biopharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Franklin Resources Inc. ($4.04M), Pictet Asset Management Holding SA ($2.98M), Braidwell LP ($1.36M), Alyeska Investment Group L.P. ($800K), Mak Capital One LLC ($622.26K), Dimensional Fund Advisors LP ($597.18K), and Millennium Management LLC ($514.48K).

Institutional investors have sold a total of 13,166,126 shares in the last 24 months. This volume of shares sold represents approximately $155.70M in transactions.

Related Companies

This page (NASDAQ:DAWN) was last updated on 5/29/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Day One Biopharmaceuticals (DAWN) Institutional Ownership

DAWN Institutional Buying and Selling by Quarter

Day One Biopharmaceuticals Major Shareholders & Ownership History

DAWN Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Day One Biopharmaceuticals (DAWN) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Day One Biopharmaceuticals (NASDAQ:DAWN)

DAWN Institutional Buying and Selling by Quarter

Day One Biopharmaceuticals Major Shareholders & Ownership History

DAWN Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of DAWN shares?

What percentage of Day One Biopharmaceuticals' stock is owned by institutional investors?

Which institutional investors have been buying Day One Biopharmaceuticals' stock?

How much institutional buying is happening at Day One Biopharmaceuticals?

Which of Day One Biopharmaceuticals' major shareholders have been selling company stock?

How much institutional selling is happening at Day One Biopharmaceuticals?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools